Global Depression Treatment Market Share 2021

1. Orion Market Research Global Depression Treatment Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027 Request a Free Sample @ https://www.omrglobal.com/request-sample/depression- treatment-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period (2020-2027). The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players are certain factors driving the growth of the depression treatment industry. To @ https://www.omrglobal.com/request-sample/depression-treatment-market learn more about this report request a free sample copy In February 2021, Zydus Cadila has received US FDA approval for Nortriptyline Hydrochloride Capsules USP. The capsules come up in the strength of 10 mg, 25 mg, 50 mg, and 75 mg. Nortriptyline Hydrochloride Capsules USP is majorly used for the treatment of depression. Browse reports/depression-treatment-market for Full Report Description@ https://www.omrglobal.com/industry- Moreover, in July 2020, VistaGen Therapeutics, a US-based biopharmaceutical company had received US FDA approval for PH94B under Phase 3 development to treat acute anxiety and mental illness in adult patients with a social anxiety disorder (SAD). PH94B is an investigational rapid-onset neurosteroid nasal spray majorly used for the treatment of social anxiety disorder. Furthermore, in March 2019, Johnson & Johnson’s ketamine-derived nasal spray Spravato for treatment-resistant depression has been approved by the FDA. The Spravato CIII Nasal Spray is used for the treatment of depressive disorder in adults with a high risk of major depressive disorder (MDD). Thus, these approvals by the FDA for antidepressant drugs produced by major key players, the depression treatment market is expected to witness significant growth during the forecast period. Market Segmentation By Drug Type Selective Serotonin Reuptake Inhibitors Tricyclic Antidepressants Serotonin-Norepinephrine Reuptake Inhibitors Monoamine Oxidase Inhibitors Others Regional Analysis North America United States  Canada

3. Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China Japan  India Rest of the Asia-Pacific Rest of the World Company Profiles Alkermes Plc Allergen Plc AstraZeneca plc Bausch Health Companies, Inc. Eli Lilly and Co. F. Hoffmann-La Roche AG Garmin Ltd. GlaxoSmithKline plc H. Lundbeck A/S Johnson & Johnson Services, Inc. Lief Therapeutics Lupin Ltd. MagVenture, Inc. Mylan N.V. Novartis AG Otsuka Pharmaceutical Co., Ltd.

4. Pfizer, Inc. Sanofi SA Takeda Pharmaceutical Co. Ltd. Teva Pharmaceutical Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/depression-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404